🔗 Share this article

Given that America proceeds with historic changes to its immunization recommendations, one figure has surfaced in a surprising turn: Høeg, a US-based physician and public health researcher who first made her name by casting doubt on coronavirus vaccinations throughout the pandemic and has focused upon possible deaths following Covid vaccination in her short position at the FDA.

Proposed Shifts to Childhood Immunization Program

Public health authorities planned to announce radical changes to the childhood immunization program in December, aligning the US with Denmark’s national calendar, according to reports – a significant shift that would put the US out of alignment with a large portion of the international standard with little proof for benefit. The announcement has been postponed until the coming year.

Rather than the top vaccines chief, Dr. Høeg is scheduled to speak at the meeting. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to run the division this calendar year.

A New Direction at the Agency

Høeg's temporary position could signify a tighter collaboration between the drug and vaccine divisions as Dr. Høeg and Dr. Prasad solidify control at the regulatory agency – and it points to a increased emphasis upon dismantling already-approved immunizations at the FDA.

Høeg has frequently advocated for discontinuing some childhood shot schedules in the US to become more like the Danish model, a society with nationalized medicine and a population about the population of the state of Wisconsin.

In her initial statements, she has continued to focus on immunizations – traditionally the purview of Prasad, director of the FDA’s vaccine center – as opposed to medication approval.

Doubts Over Expertise

The appointee has no apparent experience in pharmaceutical research, regulation or management, which has been customary for past directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a senior adviser to the commissioner and the vaccine center since March.

“She doesn’t seem to have any of the qualifications” for running the CDER, stated a neurologist and psychiatrist. “She’s never run a scientific study. She is not versed in managing a sizeable institution. She has no expertise in pharmaceutical oversight.”

Previous directors of the center would “understand regulatory frameworks and the research of pharmaceutical innovation”, said a former acting FDA commissioner. “Frankly, she has not acquired the sort of resume that prior appointees who headed CBER have had.”

This division has an immense portfolio at the FDA, she emphasized.

“Everybody just focuses on the new drug program, but the generic drug division approves thousands of generic drugs. There is also a biologic copycat branch, over-the-counter program and so forth, and every single one need to be managed,” Dr. Woodcock noted. “The responsibility you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a significant administrative element to the role, which manages over 5,000 personnel. “It is a huge administrative position, if you execute it properly,” the former official concluded.

Agency Reaction and Contentious Initiatives

When asked about questions about Høeg’s credentials and whether this assignment signifies increased cooperation among FDA leaders on immunizations, a press secretary stated that the “concerns rely on flawed premises”.

“This background is consistent with the duties of her position,” the spokesperson stated, noting the period Høeg spent advising the FDA commissioner on “drug safety and oversight research, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Høeg inherits the commissioner’s new expedited review system, a contentious rapid drug-approval program that apparently concerned her former heads. “By what process are these therapies being chosen for this voucher program? Who makes the calls?” Howard questioned. “There’s a lot of secrecy occurring at the regulatory body right now.”

Overall, he stated, “the Food and Drug Administration appears to be shifting towards less stringent regulations of all drugs, with the exception of immunizations.”

Established Past Work on Immunizations

Regarding vaccines, Dr. Høeg has a clearer, if concerning, history, Howard said. She released a study using non-validated public submissions to assess the rate of myocarditis after COVID-19 vaccination. She counseled the Florida chief medical officer Joseph Ladapo, who allegedly have changed statistics to indicate Covid vaccinations are more dangerous than they are.

Among her “wish list” for the current government included changing regulations for novel immunizations and halting “unnecessary” vaccines, she stated after the election on a podcast. At the agency, Høeg has according to sources floated the idea of excluding teenage boys from receiving Covid vaccinations.

“She’s an thorough true believer who begins with her preconceived notions and tailors the evidence to fit the evidence in a very disingenuous, untruthful way,” Howard said.

Consolidating Power and a “Revenge Tour”

Høeg became part of other skeptics, {like|